N. Underwood

Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422

T. Sorrell, C. Keighley, A. Hofmeyr, 2017 .

Changing epidemiology of candidaemia in Australia.

S. V. van Hal, T. Sorrell, C. Keighley, 2017, The Journal of antimicrobial chemotherapy.

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

S. Beatson, D. Paterson, D. Lye, 2018, The Journal of antimicrobial chemotherapy.

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study

D. Marriott, T. Sorrell, C. Keighley, 2019, BMC Infectious Diseases.

Changing epidemiology of candidaemia in Australia

S. V. van Hal, T. Sorrell, C. Keighley, 2016, The Journal of antimicrobial chemotherapy.

Risk factors for candidaemia: A prospective multi‐centre case‐control study

D. Marriott, T. Sorrell, C. Keighley, 2020, Mycoses.

Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality

S. V. van Hal, T. Sorrell, C. Keighley, 2023, Medical mycology.